Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
LQ.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
LQ.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
LQ.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
LQ.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
LQ.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LQ.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LY.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
LY.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LY.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
LY.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
LY.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
LY.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
LY.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LY.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
MD.3.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
MD.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
MD.3.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
MD.3.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
MD.3.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
MD.3.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
MD.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
MD.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BF.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BF.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BF.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BF.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
CH.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
CH.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CH.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CH.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CH.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CH.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.6EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.7.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.6ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BF.7.6ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BF.7.6EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BF.7.6EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BF.7.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.7.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BA.5.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.5.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-8626.22Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used